HSPA5 and cancer: The upregulation of BiP expression, as a master regulator of the UPR and the IRE1-XBP1 axis, strongly suggests that UPR is a hallmark of RMS tumors, which is in agreement with reports on the expression of UPR markers in several other cancers [30].